Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation

[1]  L. Goodrich,et al.  Functional interactions between Fat family cadherins in tissue morphogenesis and planar polarity , 2012, Development.

[2]  Hidemi Ito,et al.  TGF-β synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth , 2012, The Journal of experimental medicine.

[3]  Hidemi Ito,et al.  TGF-b synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth , 2012 .

[4]  R. Gibbs,et al.  Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1 , 2011, Science.

[5]  A. McKenna,et al.  The Mutational Landscape of Head and Neck Squamous Cell Carcinoma , 2011, Science.

[6]  H. Grabsch,et al.  Deletion of chromosome 4q predicts outcome in Stage II colon cancer patients , 2011, Cellular Oncology.

[7]  Benjamin J. Raphael,et al.  Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.

[8]  M. A. Basson,et al.  Characterization of a Dchs1 mutant mouse reveals requirements for Dchs1-Fat4 signaling during mammalian development , 2011, Development.

[9]  G. Halder,et al.  Hippo signaling: growth control and beyond , 2011, Development.

[10]  Xiao Xu,et al.  The xCELLigence system for real-time and label-free monitoring of cell viability. , 2011, Methods in molecular biology.

[11]  Li Li,et al.  Hippo signaling at a glance , 2010, Journal of Cell Science.

[12]  Barry S Taylor,et al.  Genomic and biological characterization of exon 4 KRAS mutations in human cancer. , 2010, Cancer research.

[13]  Nader Sanai,et al.  Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma. , 2010, World neurosurgery.

[14]  S. Croul,et al.  The SFRP family of WNT inhibitors function as novel tumor suppressor genes epigenetically silenced in medulloblastoma , 2010, Oncogene.

[15]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[16]  Derek Y. Chiang,et al.  The landscape of somatic copy-number alteration across human cancers , 2010, Nature.

[17]  S. Gabriel,et al.  Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. , 2010, Cancer cell.

[18]  Barry Merriman,et al.  U87MG Decoded: The Genomic Sequence of a Cytogenetically Aberrant Human Cancer Cell Line , 2010, PLoS genetics.

[19]  Jianmin Zhang,et al.  YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway , 2009, Nature Cell Biology.

[20]  M. Takeichi,et al.  Mammalian Fat and Dachsous cadherins regulate apical membrane organization in the embryonic cerebral cortex , 2009, The Journal of cell biology.

[21]  C. Englert,et al.  Scribble participates in Hippo signaling and is required for normal zebrafish pronephros development , 2009, Proceedings of the National Academy of Sciences.

[22]  Diane M Simeone,et al.  Oncogenic function of ATDC in pancreatic cancer through Wnt pathway activation and beta-catenin stabilization. , 2009, Cancer cell.

[23]  Chao Qi,et al.  Identification of Fat4 as a candidate tumor suppressor gene in breast cancers , 2009, International journal of cancer.

[24]  V. Velebný,et al.  The comparison of impedance-based method of cell proliferation monitoring with commonly used metabolic-based techniques. , 2009, Neuro endocrinology letters.

[25]  H. Nagatsuka,et al.  Frequent deletion of ING2 locus at 4q35.1 associates with advanced tumor stage in head and neck squamous cell carcinoma , 2009, Journal of Cancer Research and Clinical Oncology.

[26]  Simone Brabletz,et al.  E-cadherin, β-catenin, and ZEB1 in malignant progression of cancer , 2009, Cancer and Metastasis Reviews.

[27]  G. Parmigiani,et al.  Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses , 2008, Science.

[28]  D. Busam,et al.  An Integrated Genomic Analysis of Human Glioblastoma Multiforme , 2008, Science.

[29]  Joshua M. Korn,et al.  Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2008, Nature.

[30]  Manfred Gessler,et al.  Loss of Fat4 disrupts PCP signaling and oriented cell division and leads to cystic kidney disease , 2008, Nature Genetics.

[31]  J. Inazawa,et al.  Frequent silencing of a putative tumor suppressor gene melatonin receptor 1 A (MTNR1A) in oral squamous‐cell carcinoma , 2008, Cancer science.

[32]  E. Lander,et al.  Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. , 2008, Cancer research.

[33]  S. Baylin,et al.  Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer , 2008, British Journal of Cancer.

[34]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[35]  E. Lander,et al.  Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma , 2007, Proceedings of the National Academy of Sciences.

[36]  John E. Major,et al.  Genomic mutation consequence calculator , 2007, Bioinform..

[37]  Guy Cavet,et al.  Comment on "The Consensus Coding Sequences of Human Breast and Colorectal Cancers" , 2007, Science.

[38]  T. Miki,et al.  Identification of homozygous deletions of tumor suppressor gene FAT in oral cancer using CGH-array , 2007, Oncogene.

[39]  M. Toyota,et al.  Frequent epigenetic inactivation of SFRP genes and constitutive activation of Wnt signaling in gastric cancer , 2007, Oncogene.

[40]  Rebecca A Betensky,et al.  Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment. , 2007, Clinical cancer research : an official journal of the American Association for Cancer Research.

[41]  Ratnesh K Singh,et al.  Deletions in chromosome 4 differentially associated with the development of cervical cancer: evidence of slit2 as a candidate tumor suppressor gene , 2007, Human Genetics.

[42]  Ken Chen,et al.  PolyScan: an automatic indel and SNP detection approach to the analysis of human resequencing data. , 2007, Genome research.

[43]  P. A. Futreal,et al.  Loss of the Mismatch Repair Protein MSH6 in Human Glioblastomas Is Associated with Tumor Progression during Temozolomide Treatment , 2007, Clinical Cancer Research.

[44]  Hans Clevers,et al.  Wnt/β-Catenin Signaling in Development and Disease , 2006, Cell.

[45]  G. Parmigiani,et al.  The Consensus Coding Sequences of Human Breast and Colorectal Cancers , 2006, Science.

[46]  M. Katoh,et al.  Comparative integromics on FAT1, FAT2, FAT3 and FAT4. , 2006, International journal of molecular medicine.

[47]  M. Fraga,et al.  Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer , 2006, Oncogene.

[48]  R. Cameron,et al.  Cyclooxygenase-2-dependent regulation of E-cadherin: prostaglandin E(2) induces transcriptional repressors ZEB1 and snail in non-small cell lung cancer. , 2006, Cancer research.

[49]  N. Sibinga,et al.  The Fat1 cadherin integrates vascular smooth muscle cell growth and migration signals , 2006, The Journal of cell biology.

[50]  Tracy T Batchelor,et al.  A hypermutation phenotype and somatic MSH6 mutations in recurrent human malignant gliomas after alkylator chemotherapy. , 2006, Cancer research.

[51]  S. Baylin,et al.  Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction? , 2006, Nature Reviews Cancer.

[52]  野島 正寛.  Frequent epigenetic inactivation of SFRP genes and constitutive activation of Wnt signaling in gastric cancer , 2006 .

[53]  H. Clevers.  Wnt/beta-catenin signaling in development and disease. , 2006, Cell.

[54]  M. Gessler,et al.  Expression of mouse dchs1, fjx1, and fat‐j suggests conservation of the planar cell polarity pathway identified in drosophila , 2005, Developmental dynamics : an official publication of the American Association of Anatomists.

[55]  Jianbin Huang,et al.  The Hippo Signaling Pathway Coordinately Regulates Cell Proliferation and Apoptosis by Inactivating Yorkie, the Drosophila Homolog of YAP , 2005, Cell.

[56]  Kwonseop Kim,et al.  Identification of MYCBP as a β-catenin/LEF-1 target using DNA microarray analysis , 2005 .

[57]  M. Takeichi,et al.  New insights into Fat cadherins , 2005, Journal of Cell Science.

[58]  H. Clevers,et al.  Wnt signalling in stem cells and cancer , 2005, Nature.

[59]  Kwonseop Kim,et al.  Identification of MYCBP as a beta-catenin/LEF-1 target using DNA microarray analysis. , 2005, Life sciences.

[60]  S. Aaronson,et al.  An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells. , 2004, Cancer cell.

[61]  G. Saldanha,et al.  Nuclear β‐catenin in basal cell carcinoma correlates with increased proliferation , 2004, The British journal of dermatology.

[62]  S. Baumgartner,et al.  The fat-like Gene of Drosophila Is the True Orthologue of Vertebrate Fat Cadherins and Is Involved in the Formation of Tubular Organs* , 2004, Journal of Biological Chemistry.

[63]  M. Takeichi,et al.  Mammalian Fat1 cadherin regulates actin dynamics and cell–cell contact , 2004, The Journal of cell biology.

[64]  Wei Dong Chen,et al.  Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer , 2004, Nature Genetics.

[65]  Yvonne Wallis,et al.  The Wnt Antagonist sFRP1 in Colorectal Tumorigenesis , 2004, Cancer Research.

[66]  Douglas A. Hosack,et al.  Identifying biological themes within lists of genes with EASE , 2003, Genome Biology.

[67]  B. Gumbiner,et al.  Adhesion-independent mechanism for suppression of tumor cell invasion by E-cadherin , 2003, The Journal of cell biology.

[68]  Carmen Birchmeier,et al.  beta-Catenin signals regulate cell growth and the balance between progenitor cell expansion and differentiation in the nervous system. , 2003, Developmental biology.

[69]  C. ffrench-Constant,et al.  Mice Lacking the Giant Protocadherin mFAT1 Exhibit Renal Slit Junction Abnormalities and a Partially Penetrant Cyclopia and Anophthalmia Phenotype , 2003, Molecular and Cellular Biology.

[70]  J. Behrens,et al.  The Wnt signaling pathway and its role in tumor development , 2003, Journal of Cancer Research and Clinical Oncology.

[71]  Susan Summers,et al.  Regulation of endothelial barrier function and growth by VE-cadherin, plakoglobin, and beta-catenin. , 2002, American journal of physiology. Cell physiology.

[72]  K. Kinzler,et al.  Targeted inactivation of CTNNB1 reveals unexpected effects of β-catenin mutation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[73]  Kathleen R. Cho,et al.  ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with beta-catenin defects and promotes neoplastic transformation. , 2002, Cancer cell.

[74]  K. Kinzler,et al.  Targeted inactivation of CTNNB1 reveals unexpected effects of beta-catenin mutation. , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[75]  Wayne A. Phillips,et al.  Id2 Is a Target of the β-Catenin/T Cell Factor Pathway in Colon Carcinoma* , 2001, The Journal of Biological Chemistry.

[76]  K. Aldape,et al.  Formation of intracranial tumors by genetically modified human astrocytes defines four pathways critical in the development of human anaplastic astrocytoma. , 2001, Cancer research.

[77]  B. Gumbiner,et al.  E-Cadherin Suppresses Cellular Transformation by Inhibiting β-Catenin Signaling in an Adhesion-Independent Manner , 2001, The Journal of cell biology.

[78]  B. Geiger,et al.  Cadherin sequences that inhibit beta-catenin signaling: a study in yeast and mammalian cells. , 2001, Molecular biology of the cell.

[79]  S. Rockman,et al.  Id2 is a target of the beta-catenin/T cell factor pathway in colon carcinoma. , 2001, The Journal of biological chemistry.

[80]  N. Niikawa,et al.  Involvement of claudin-1 in the beta-catenin/Tcf signaling pathway and its frequent upregulation in human colorectal cancers. , 2001, Oncology research.

[81]  Elizabeth M. Smigielski,et al.  dbSNP: the NCBI database of genetic variation , 2001, Nucleic Acids Res..

[82]  David I. Smith,et al.  Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating β-catenin/TCF signalling , 2000, Nature Genetics.

[83]  David I. Smith,et al.  Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling (vol 26, pg 146, 2000) , 2000 .

[84]  S. Orsulic,et al.  E-cadherin binding prevents beta-catenin nuclear localization and beta-catenin/LEF-1-mediated transactivation. , 1999, Journal of cell science.

[85]  B. Geiger,et al.  Inhibition of β-catenin-mediated transactivation by cadherin derivatives , 1998 .

[86]  Kenneth M. Yamada,et al.  Modulation of cell-cell adherens junctions by surface clustering of the N-cadherin cytoplasmic tail. , 1998, Experimental cell research.

[87]  A. Sparks,et al.  Identification of c-MYC as a target of the APC pathway. , 1998, Science.

[88]  Benjamin Geiger,et al.  Differential Nuclear Translocation and Transactivation Potential of β-Catenin and Plakoglobin , 1998, The Journal of cell biology.

[89]  P. Green,et al.  Consed: a graphical tool for sequence finishing. , 1998, Genome research.

[90]  B. Geiger,et al.  Inhibition of beta-catenin-mediated transactivation by cadherin derivatives. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[91]  W F Bodmer,et al.  Beta-catenin mutations in cell lines established from human colorectal cancers. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[92]  D. Nickerson,et al.  PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing. , 1997, Nucleic acids research.

[93]  K. Kinzler,et al.  Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC−/− Colon Carcinoma , 1997, Science.

[94]  Hans Clevers,et al.  Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC , 1997, Science.

[95]  Michael Kühl,et al.  Functional interaction of β-catenin with the transcription factor LEF-1 , 1996, Nature.

[96]  Hans Clevers,et al.  XTcf-3 Transcription Factor Mediates β-Catenin-Induced Axis Formation in Xenopus Embryos , 1996, Cell.

[97]  H. Höfler,et al.  No Evidence for Mutations in the α- and β-Catenin Genes in Human Gastric and Breast Carcinomas , 1996 .

[98]  H. Höfler,et al.  No evidence for mutations in the alpha- and beta-catenin genes in human gastric and breast carcinomas. , 1996, Cancer research.

[99]  R Grosschedl,et al.  Functional interaction of beta-catenin with the transcription factor LEF-1. , 1996, Nature.

[100]  R. Poulsom,et al.  Molecular cloning and tissue expression of FAT, the human homologue of the Drosophila fat gene that is located on chromosome 4q34-q35 and encodes a putative adhesion molecule. , 1995, Genomics.

[101]  M. Takeichi.  Morphogenetic roles of classic cadherins. , 1995, Current opinion in cell biology.

[102]  S Ichii,et al.  Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. , 1992, Human molecular genetics.

[103]  Peter J. Bryant,et al.  The fat tumor suppressor gene in Drosophila encodes a novel member of the cadherin gene superfamily , 1991, Cell.

[104]  M. Baer,et al.  Structure and transcription of a human gene for H1 RNA, the RNA component of human RNase P , 1990, Nucleic Acids Res..

[105]  P J Bryant,et al.  Mutations at the fat locus interfere with cell proliferation control and epithelial morphogenesis in Drosophila. , 1988, Developmental biology.

[106]  S. Orsulic,et al.  E-cadherin binding prevents β-catenin nuclear localization and β-catenin / LEF-1-mediated transactivation , 2022 .